21 Cfr 809 (2024)

1. 21 CFR Part 809 -- In Vitro Diagnostic Products for Human Use - eCFR

  • General requirements for manufacturers and producers of in vitro diagnostic products. § 809.30, Restrictions on the sale, distribution and use of analyte ...

  • (a) The label for an in vitro diagnostic product shall state the following information, except where such information is not applicable, or as otherwise specified in a standard for a particular product class or as provided in paragraph (e) of this section. Section 201(k) of the act provides that “a requirement made by or under authority of this act that any word, statement, or other information appear on the label shall not be considered to be complied with unless such word, statement, or other information also appears on the outside container or wrapper, if any there be, of the retail package of such article, or is easily legible through the outside container or wrapper.”

2. CFR - Code of Federal Regulations Title 21 - FDA

  • TITLE 21--FOOD AND DRUGS CHAPTER I--FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES SUBCHAPTER H - MEDICAL DEVICES. PART 809, IN VITRO ...

  • -

3. 21 CFR Part 809 -- In Vitro Diagnostic Products for Human Use - eCFR

  • General requirements for manufacturers and producers of in vitro diagnostic products. § 809.30, Restrictions on the sale, distribution and use of ...

  • You are using an unsupported browser

4. In vitro diagnostic - CFR - Code of Federal Regulations Title 21 - FDA

  • (a) In vitro diagnostic products are those reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, ...

  • (a) The label for an in vitro diagnostic product shall state the following information, except where such information is not applicable, or as otherwise specified in a standard for a particular product class or as provided in paragraph (e) of this section. Section 201(k) of the act provides that "a requirement made by or under authority of this act that any word, statement, or other information appear on the label shall not be considered to be complied with unless such word, statement, or other information also appears on the outside container or wrapper, if any there be, of the retail package of such article, or is easily legible through the outside container or wrapper."

5. 21 CFR Part 809 | US Law | LII / Legal Information Institute

21 CFR Part 809 | US Law | LII / Legal Information Institute

6. 21 CFR 809 - In-Vitro Diagnostic Products - GMP Publications

  • 21 CFR 809 - In-Vitro Diagnostic Products. 10Part809-1.jpg 1-933734-46-9. US FDA Title 21 CFR Parts. Part 809 - In Vitro Diagnostic Products for Human Use ...

  • GMP Publications, Part 809 - In-Vitro Diagnostic Products

7. [PDF] Food and Drug Administration 21 CFR Part 809 [Docket No. FDA-2023-N ...

  • 29 sep 2023 · Act and FDA's regulations. IVDs are also subject to specific labeling requirements in part 809 of the regulations (21 CFR part 809). D ...

8. CFR - Code of Federal Regulations Title 21 - accessdata.fda.gov

  • PART 809 -- IN VITRO DIAGNOSTIC PRODUCTS FOR HUMAN USE. Subpart B - Labeling. Sec. 809.11 Exceptions or alternatives to labeling requirements for in vitro ...

  • (a) The appropriate FDA Center Director may grant an exception or alternative to any provision listed in paragraph (f) of this section and not explicitly required by statute, for specified lots, batches, or other units of an in vitro diagnostic product for human use, if the Center Director determines that compliance with such labeling requirement could adversely affect the safety, effectiveness, or availability of such products that are or will be included in the Strategic National Stockpile.

9. 21 CFR § 809.20 - General requirements for manufacturers and ...

  • CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES · SUBCHAPTER H—MEDICAL DEVICES · PART 809—IN VITRO DIAGNOSTIC PRODUCTS FOR HUMAN ...

  • § 809.20 General requirements for manufacturers and producers of in vitro diagnostic products.

21 CFR § 809.20 - General requirements for manufacturers and ...

10. 21 CFR 809 In Vitro Diagnostic Products for Human Use with TOC

  • 21 CFR 809 In Vitro Diagnostic Products for Human Use with TOC. Posted on March 20, 2022 April 20, 2022 by QS Compliance. View in Full Screen. Page 1 / 13.

  • Awards & Memberships

11. 809.30 - CFR - Code of Federal Regulations Title 21 - FDA

  • PART 809 -- IN VITRO DIAGNOSTIC PRODUCTS FOR HUMAN USE. Subpart C - Requirements for Manufacturers and Producers. Sec. 809.30 Restrictions on the sale ...

  • (a) Analyte specific reagents (ASR's) (§ 864.4020 of this chapter) are restricted devices under section 520(e) of the Federal Food, Drugs, and Cosmetic Act (the act) subject to the restrictions set forth in this section.

12. IN VITRO DIAGNOSTIC PRODUCTS FOR HUMAN USE - Chan Robles

  • 21 C.F.R. PART 809--IN VITRO DIAGNOSTIC PRODUCTS FOR HUMAN USE. TITLE 21--Food and Drugs. CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND ...

  • US LAWS, STATUTES & CODES ON-LINE : chanrobles.com

13. 21 CFR 809.10 - Labeling for in vitro diagnostic products. - CustomsMobile

  • Title 21 - Food and Drugs last revised: Mar 22, 2024. All TitlesTitle 21Chapter IPart 809Subpart B - Subpart B—Labeling · View all text of Subpart B [§ 809.10 ...

  • Get on top of your trade by knowing the regulations that govern it! Learn how 19 CFR affects you by gaining sound knowledge of the Code of Federal Regulations and the Customs Import and Export Regulations in the US.

14. Food and Drug Administration Regulation of in Vitro Diagnostic ...

  • 2 nov 2004 · Labeling devices in accordance with labeling regulations in 21 CFR Part 801 or 809. Submission of a premarket notification [510(k)] before ...

  • The Food and Drug Administration regulates the sale and distribution of laboratory devices under a statutory and regulatory framework that is unfamiliar to most clinical laboratory scientists. In this article we briefly describe the criteria that are ...

Food and Drug Administration Regulation of in Vitro Diagnostic ...

15. [PDF] Draft Guidance for Industry and FDA Staff In Vitro Diagnostic (IVD ...

  • 25 okt 2007 · This is not an all-inclusive list. Title 21, Code of Federal Regulations (21 CFR) ... Part 809, In Vitro Diagnostic Products for Human Use.

16. Use of Certain Symbols in Labeling - Federal Register

  • 19 apr 2013 · CFR: 21 CFR 660: 21 CFR 801: 21 CFR 809; Agency/Docket Number: Docket No. FDA-2013-N-0125; RIN: 0910-AG74; Document Number: 2013-09175. Document ...

  • The Food and Drug Administration (FDA) is proposing to revise medical device and biological product labeling regulations to explicitly allow for the inclusion of stand-alone graphical representations of information, or symbols, if the symbol has been established as part of a standard developed by...

Use of Certain Symbols in Labeling - Federal Register

17. CFR - Code of Federal Regulations Title 21 - FDA

  • CFR - Code of Federal Regulations Title 21. Print; Share 1 ... CFR Title 21 - Food and Drugs: Parts 800 to 1299 ... 809, In vitro diagnostic products for human use ...

  • -

18. 809.40 - CFR - Code of Federal Regulations Title 21 - FDA

  • PART 809 -- IN VITRO DIAGNOSTIC PRODUCTS FOR HUMAN USE. Subpart C - Requirements for Manufacturers and Producers. Sec. 809.40 Restrictions on the sale ...

  • -

21 Cfr 809 (2024)

References

Top Articles
Latest Posts
Article information

Author: Domingo Moore

Last Updated:

Views: 5950

Rating: 4.2 / 5 (73 voted)

Reviews: 80% of readers found this page helpful

Author information

Name: Domingo Moore

Birthday: 1997-05-20

Address: 6485 Kohler Route, Antonioton, VT 77375-0299

Phone: +3213869077934

Job: Sales Analyst

Hobby: Kayaking, Roller skating, Cabaret, Rugby, Homebrewing, Creative writing, amateur radio

Introduction: My name is Domingo Moore, I am a attractive, gorgeous, funny, jolly, spotless, nice, fantastic person who loves writing and wants to share my knowledge and understanding with you.